End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.95 MXN | -0.88% | -3.09% | +19.70% |
Sales 2023 | 16.47B 986M | Sales 2024 * | 17.82B 1.07B | Capitalization | 15.75B 943M |
---|---|---|---|---|---|
Net income 2023 | 1.03B 61.71M | Net income 2024 * | 1.98B 118M | EV / Sales 2023 | 1.07 x |
Net Debt 2023 | 4.52B 271M | Net Debt 2024 * | 3.04B 182M | EV / Sales 2024 * | 1.05 x |
P/E ratio 2023 |
13.1
x | P/E ratio 2024 * |
7.7
x | Employees | 1,783 |
Yield 2023 |
1.38% | Yield 2024 * |
-
| Free-Float | 69.81% |
Latest transcript on Genomma Lab Internacional, S.A.B. de C.V.
1 day | -0.88% | ||
1 week | -3.09% | ||
Current month | +1.44% | ||
1 month | +18.04% | ||
3 months | +33.89% | ||
6 months | +20.64% | ||
Current year | +19.70% |
Managers | Title | Age | Since |
---|---|---|---|
Marco Sparvieri
CEO | Chief Executive Officer | - | - |
Founder | - | 96-10-29 | |
Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Burkhard Wittek
BRD | Director/Board Member | 70 | 18-04-17 |
Director/Board Member | - | - | |
Founder | - | 96-10-29 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.07% | 15 M€ | -1.62% | - | |
0.04% | 32 M€ | +8.75% | - | |
0.01% | 4 M€ | -4.41% | - | |
0.01% | 112 M€ | +5.51% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 16.95 | -0.88% | 3,143,736 |
24-05-15 | 17.1 | +0.83% | 5,776,938 |
24-05-14 | 16.96 | -1.85% | 2,451,974 |
24-05-13 | 17.28 | -0.29% | 1,752,150 |
24-05-10 | 17.33 | -0.91% | 2,873,264 |
End-of-day quote Mexican S.E., May 15, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.70% | 943M | |
+32.36% | 694B | |
+30.77% | 593B | |
-1.60% | 371B | |
+20.07% | 331B | |
+6.04% | 290B | |
+14.77% | 239B | |
+9.13% | 209B | |
-3.97% | 209B | |
+9.27% | 169B |
- Stock Market
- Equities
- LAB B Stock